- Lobbying
- Lobbying by 510 K Coalition
Lobbying Relationship
Bills mentioned
S.510: FDA Food Safety Modernization Act
Sponsor: Richard J. Durbin (D-Ill.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Vince Ventimiglia | Senate, HHS |
JENNIFER CAREY | House |
Vincent Ventimiglia Jr | Assist. Secretary for Legislation - HHS Assist. Sec. for Legislation - HHS |
VINCENT VENTIMIGLIA | ASSIST. SECRETARY OF LEGISLATIVE AFFAIR ASSIST. SECRETARY OF LEGISLATION - HHS ASSIST.SECRETARY OF LEGISLATION - HHS ASSIST.SECRETARY FOR LEGISLATION - HHS ASSIST. SECRETARY OF LEGISLATION, HHS |
Vince Ventimiglia Jr. | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Amendment
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Type of Issue
Registration
Issue(s) they said they’d lobby about: FDA's 510 (K) review process for medical devices; reauthorization of Medical Devise User Fee ACt (MDUFA).
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate